Cargando…

Monitoring the quality of SARS‐CoV‐2 virus detection in molecular diagnostic laboratories in the Eastern Mediterranean Region during the COVID‐19 pandemic

INTRODUCTION: The COVID‐19 pandemic placed unprecedented stress on laboratories in the Eastern Mediterranean Region. Building on existing capacity for influenza diagnostics, countries introduced COVID‐19 diagnostic support to ~100% regional coverage. A key challenge during the expansion was maintain...

Descripción completa

Detalles Bibliográficos
Autores principales: Meredith, Luke W., Aboualy, Mustafa, Ochola, Rachel, Ozel, Mehmet, Abubakar, Abdinasir, Barakat, Amal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10654553/
https://www.ncbi.nlm.nih.gov/pubmed/38019698
http://dx.doi.org/10.1111/irv.13217
_version_ 1785147857979834368
author Meredith, Luke W.
Aboualy, Mustafa
Ochola, Rachel
Ozel, Mehmet
Abubakar, Abdinasir
Barakat, Amal
author_facet Meredith, Luke W.
Aboualy, Mustafa
Ochola, Rachel
Ozel, Mehmet
Abubakar, Abdinasir
Barakat, Amal
author_sort Meredith, Luke W.
collection PubMed
description INTRODUCTION: The COVID‐19 pandemic placed unprecedented stress on laboratories in the Eastern Mediterranean Region. Building on existing capacity for influenza diagnostics, countries introduced COVID‐19 diagnostic support to ~100% regional coverage. A key challenge during the expansion was maintaining quality testing in laboratories, ensuring that correct results were shared with medical facilities. METHODS: WHO organized two rounds of independently monitored severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2) external quality assurance programs (EQAP). The Public Health Laboratory (PHL) division of WHO supplied external quality assurance (EQA) panels, from the Royal College of Pathologists of Australasia Quality Assurance Programme (RCPAQAP) Australia to laboratories not enrolled in recurring Global Influenza Surveillance and Response System (GISRS) quality assurance programs, in which national influenza centers routinely participate. RESULTS: Fifteen and 14 countries participated in PHL/EQAP for SARS‐CoV‐2 between 2020 and 2022. Concordance was consistent between rounds, reaching 96.4% and 89.9%. A separate assessment of GISRS/EQAP to national‐level laboratories identified high levels of response and concordance for SARS‐CoV‐2 (100% response, 93% concordance), which was reduced for influenza (50% response rate, 80% concordance), reflecting the challenge of prioritizing pathogens during outbreaks. CONCLUSION: The proliferation of laboratories in response to COVID‐19 was a success story from the pandemic. However, monitoring the quality of laboratories was challenging via existing EQAP. The addition of PHL/EQAP provided a mechanism to monitor performance of laboratories that were not designated as national influenza centers. While a high proportion of laboratories attained good results, continual emphasis on quality and enrollment in EQAP is key to ensuring sustainability of laboratory testing in future.
format Online
Article
Text
id pubmed-10654553
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-106545532023-11-17 Monitoring the quality of SARS‐CoV‐2 virus detection in molecular diagnostic laboratories in the Eastern Mediterranean Region during the COVID‐19 pandemic Meredith, Luke W. Aboualy, Mustafa Ochola, Rachel Ozel, Mehmet Abubakar, Abdinasir Barakat, Amal Influenza Other Respir Viruses Original Articles INTRODUCTION: The COVID‐19 pandemic placed unprecedented stress on laboratories in the Eastern Mediterranean Region. Building on existing capacity for influenza diagnostics, countries introduced COVID‐19 diagnostic support to ~100% regional coverage. A key challenge during the expansion was maintaining quality testing in laboratories, ensuring that correct results were shared with medical facilities. METHODS: WHO organized two rounds of independently monitored severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2) external quality assurance programs (EQAP). The Public Health Laboratory (PHL) division of WHO supplied external quality assurance (EQA) panels, from the Royal College of Pathologists of Australasia Quality Assurance Programme (RCPAQAP) Australia to laboratories not enrolled in recurring Global Influenza Surveillance and Response System (GISRS) quality assurance programs, in which national influenza centers routinely participate. RESULTS: Fifteen and 14 countries participated in PHL/EQAP for SARS‐CoV‐2 between 2020 and 2022. Concordance was consistent between rounds, reaching 96.4% and 89.9%. A separate assessment of GISRS/EQAP to national‐level laboratories identified high levels of response and concordance for SARS‐CoV‐2 (100% response, 93% concordance), which was reduced for influenza (50% response rate, 80% concordance), reflecting the challenge of prioritizing pathogens during outbreaks. CONCLUSION: The proliferation of laboratories in response to COVID‐19 was a success story from the pandemic. However, monitoring the quality of laboratories was challenging via existing EQAP. The addition of PHL/EQAP provided a mechanism to monitor performance of laboratories that were not designated as national influenza centers. While a high proportion of laboratories attained good results, continual emphasis on quality and enrollment in EQAP is key to ensuring sustainability of laboratory testing in future. John Wiley and Sons Inc. 2023-11-17 /pmc/articles/PMC10654553/ /pubmed/38019698 http://dx.doi.org/10.1111/irv.13217 Text en © 2023 World Health Organization; licensed by John Wiley & Sons Ltd. Influenza and Other Respiratory Viruses published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Articles
Meredith, Luke W.
Aboualy, Mustafa
Ochola, Rachel
Ozel, Mehmet
Abubakar, Abdinasir
Barakat, Amal
Monitoring the quality of SARS‐CoV‐2 virus detection in molecular diagnostic laboratories in the Eastern Mediterranean Region during the COVID‐19 pandemic
title Monitoring the quality of SARS‐CoV‐2 virus detection in molecular diagnostic laboratories in the Eastern Mediterranean Region during the COVID‐19 pandemic
title_full Monitoring the quality of SARS‐CoV‐2 virus detection in molecular diagnostic laboratories in the Eastern Mediterranean Region during the COVID‐19 pandemic
title_fullStr Monitoring the quality of SARS‐CoV‐2 virus detection in molecular diagnostic laboratories in the Eastern Mediterranean Region during the COVID‐19 pandemic
title_full_unstemmed Monitoring the quality of SARS‐CoV‐2 virus detection in molecular diagnostic laboratories in the Eastern Mediterranean Region during the COVID‐19 pandemic
title_short Monitoring the quality of SARS‐CoV‐2 virus detection in molecular diagnostic laboratories in the Eastern Mediterranean Region during the COVID‐19 pandemic
title_sort monitoring the quality of sars‐cov‐2 virus detection in molecular diagnostic laboratories in the eastern mediterranean region during the covid‐19 pandemic
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10654553/
https://www.ncbi.nlm.nih.gov/pubmed/38019698
http://dx.doi.org/10.1111/irv.13217
work_keys_str_mv AT meredithlukew monitoringthequalityofsarscov2virusdetectioninmoleculardiagnosticlaboratoriesintheeasternmediterraneanregionduringthecovid19pandemic
AT aboualymustafa monitoringthequalityofsarscov2virusdetectioninmoleculardiagnosticlaboratoriesintheeasternmediterraneanregionduringthecovid19pandemic
AT ocholarachel monitoringthequalityofsarscov2virusdetectioninmoleculardiagnosticlaboratoriesintheeasternmediterraneanregionduringthecovid19pandemic
AT ozelmehmet monitoringthequalityofsarscov2virusdetectioninmoleculardiagnosticlaboratoriesintheeasternmediterraneanregionduringthecovid19pandemic
AT abubakarabdinasir monitoringthequalityofsarscov2virusdetectioninmoleculardiagnosticlaboratoriesintheeasternmediterraneanregionduringthecovid19pandemic
AT barakatamal monitoringthequalityofsarscov2virusdetectioninmoleculardiagnosticlaboratoriesintheeasternmediterraneanregionduringthecovid19pandemic